{
    "id": 22912,
    "cites": 10,
    "cited_by": 1,
    "reference": [
        "Rena M. Conti and Ernst R. Berndt, Anatomy of U.S. cancer drug shortages: Technology, market structure and price competition, Working Paper (2013).",
        "Adam J. Fein, Retail generic drug costs go up up and away, www.drugchannels.net (2013).",
        "Erin R. Fox, Drug shortage update current status and signi\u00c3\u00af\u00c2\u00ac\u00c2\u0081cant trends, Online presentation: http://www.fda.gov/downloads/Drugs/NewsEvents/UCM274565.pdf (2011).",
        "John R. Graham, The shortage of generic sterile injectable drugs: Diagnosis and solutions, Mackinac Center Policy Brief (2012).",
        "K Haninger, A Jessup, and MA Koehler, Economic analysis of the causes of drug shortages, ASPE Issue Brief (Department of Health and Human Services, O\u00c3\u00af\u00c2\u00ac\u00c6\u0092ce of the Assistant Secretary for Planning) (2011).",
        ", http://www.ashp.org/menu/drugshortages/faqs.html, ASHP Website, accessed May 2014 (2014).",
        "US Government Accountability O\u00c3\u00af\u00c2\u00ac\u00c6\u0092ce, Drug shortages\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009dFDAs ability to respond should be strengthened (GAO-12-116), United States Government Accountability O\u00c3\u00af\u00c2\u00ac\u00c6\u0092ce (2011).",
        ", Drug shortages\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009dpublic health threat continues, despite e\u00c3\u00af\u00c2\u00ac\u00e2\u0082\u00acorts to help ensure product availability (GAO-14-194), United States Government Accountability O\u00c3\u00af\u00c2\u00ac\u00c6\u0092ce (2014).",
        "Sta\u00c3\u00af\u00c2\u00ac\u00e2\u0082\u00ac report, FDAs contribution to the drug shortage crisis, U.S. House of Representativesw 112th Congress Committee on Oversight and Government Reform (2012).",
        "Ali Yurukoglu, Medicare reimbursements and shortages of sterile injectable pharmaceuticals, National Bureau of Economic Research Working Paper No. 17987 (2012)."
    ]
}